BEDC: AB BioTechnologies Breaks Ground on $10.5M Project

BEDC Bloomington Economic Development Corporation logo

BLOOMINGTON, Ind. (May 31, 2017) – Construction has begun on a new 23,000-square foot pharmaceutical manufacturing facility for AB BioTechnologies in Monroe County. The company is a contract development and manufacturing organization (CDMO), and plans to add clinical and small-scale commercial manufacturing for injectable drugs later this year. AB BioTechnologies announced it was expanding in …

read more

Indiana Small Businesses Honored for Entrepreneurial Success

EDGE Awards

EDGE Awards highlight impact of small businesses, which employ 1.2 million Hoosiers SPEEDWAY, Ind. (May 3, 2017) – Lt. Governor Suzanne Crouch and Linda McMahon, administrator of the U.S. Small Business Administration (SBA), honored multiple Indiana businesses today with the Economic Development and Growth Through Entrepreneurship (EDGE) Awards, recognizing each company for its work to help …

read more

AB BioTechnologies selects Vanrx Pharmasystems aseptic filling and lyophilizer loading workcells

VanRX Logo

BLOOMINGTON, INDIANA – MARCH 7, 2017 – AB BioTechnologies (AB), a provider of contract development and manufacturing services for the pharmaceutical industry, has selected Vanrx Pharmasystems to provide aseptic filling and lyophilizer loading systems for its new facility. AB is expanding its services to enable customers to develop new drug products from preclinical through clinical …

read more

Drug Development Company Adding Contract Manufacturing Services

AB BioTechnologies Expansion Vials in state-of-the-art fill line

Firm’s growth will support Indiana’s $62 billion life sciences industry BLOOMINGTON, Ind. (Jan. 11, 2017) – AB BioTechnologies, a pharmaceutical development company, announced plans today to add new contract manufacturing operations in Bloomington, creating up to 33 new high-wage jobs by 2020. “AB BioTechnologies showcases the big impact small businesses are making in communities around …

read more

AB BioTechnologies Expanding in Monroe County

BLOOMINGTON, Ind. (Jan. 11, 2017) – AB BioTechnologies, a pharmaceutical development company located in Monroe County, will invest $10.5 million to construct and equip a new 23,000 square foot manufacturing facility in Monroe County, and create up to 33 new high-wage jobs by 2020. The company will add manufacturing services for formulating, filling, freeze-drying, and …

read more

AB BioTechnologies, Inc. Expands Services with the Addition of Pre-Clinical Manufacturing Capabilities

GLP Manufacturing

BLOOMINGTON – September 21, 2016 – AB BioTechnologies, Inc., a privately-held pharmaceutical contract service provider, announced today it is expanding its services to include Pre-Clinical manufacturing at its Bloomington, Indiana facility. New drug candidates must undergo pre-clinical studies to establish a toxicology profile and assess the safety, efficacy and bioactivity prior to filing an Investigational …

read more

Hands-on Lyophilization Training 2016

Would you like to learn thermal characterization and lyophilization development in a hands-on course? Join Dr. Schwegman at SP Scientific’s four day training course “Lyophilization Cycle Development and Optimization”! Gain valuable practical experience with the lyophilization optimization tools and equipment in a small class. Course objectives: Initial optimization of lyophilization cycle development Considerations and characteristics in …

read more

IEDC Awards Training Grant, Tax Credit

AB BioTechnologies received funds for a $20,000 training grant from the Indiana Economic Development Corporation’s Skills Enhancement Fund. The funding covered training for company employees that are Indiana residents. Additionally, the company will receive up to $65,000 in Economic Development for a Growing Economy (EDGE) tax credits over a 10-year period. Source

read more

Indiana Life Sciences Company Expands

AB BioTechnologies Announces Expansion With the expansion in 2016 and 2017, AB BioTechnologies will increase their workforce by 20 or more employees including scientists, operators, and support staff. They are planning on a $9 million to $10 million investment in a new building, manufacturing equipment, and lab equipment to begin manufacturing early phase clinical supplies. Based on current …

read more